Keros Therapeutics Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Keith Regnante | 2 | -80,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 0 | 40,000 | -40,000 |
最近12个月 | 0 | 80,000 | -80,000 |
Keros Therapeutics Inc 内部交易
Keros Therapeutics Inc 最新内部交易
Keith Regnante | CFO | 2023-11-04 | 卖出 | 40,000 | - |
$45.29
|
+23.75%
|
Keith Regnante | CFO | 2023-06-09 | 卖出 | 40,000 | - |
$46.61
|
+20.24%
|
Jennifer Lachey | Chief Scientific Officer | 2022-07-15 | 卖出 | 46,034 | 95,100 |
$30
|
+86.82%
|
Jennifer Lachey | Chief Scientific Officer | 2022-07-13 | 卖出 | 1,916 | 95,100 |
$30
|
+86.82%
|
Jennifer Lachey | Chief Scientific Officer | 2022-05-11 | 卖出 | 5,300 | 85,700 |
$41.9
|
+33.76%
|
Jennifer Lachey | Chief Scientific Officer | 2022-04-11 | 卖出 | 5,300 | 85,700 |
$62.77
|
-10.71%
|
Christopher Rovaldi | COO | 2022-04-06 | 卖出 | 1,728 | - |
$65
|
-13.78%
|
Jennifer Lachey | Chief Scientific Officer | 2022-04-04 | 卖出 | 7,950 | 85,700 |
$60
|
-6.59%
|
Christopher Rovaldi | COO | 2022-04-01 | 卖出 | 864 | - |
$57.49
|
-2.51%
|
Jennifer Lachey | Chief Scientific Officer | 2022-02-11 | 卖出 | 2,650 | 85,700 |
$52.06
|
+7.65%
|